Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production
(Q52529596)
scientific article published on March 15, 1998
scientific article published on March 15, 1998
Language: